1. Ghost authors revealed: The structure and function of human N6‐methyladenosine RNA methyltransferases
   Kurtis Breger et al, 2024, WIREs RNA CrossRef
2. Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence
   Qianru Zhu et al, 2022, Frontiers in Genetics CrossRef
3. N6-methyladenosine modifications in maternal-fetal crosstalk and gestational diseases
   Suqi Wu et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
4. L3MBTL2-mediated CGA transcriptional suppression promotes pancreatic cancer progression through modulating autophagy
   Hua Huang et al, 2022, iScience CrossRef
5. Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy
   Angel Guan et al, 2024, Cancer Medicine CrossRef
6. METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression
   Zihao Dai et al, 2023, Molecular Therapy CrossRef
7. Reniformin A suppresses non-small cell lung cancer progression by inducing TLR4/NLRP3/caspase-1/GSDMD-dependent pyroptosis
   Huiyu Zhu et al, 2024, International Immunopharmacology CrossRef
8. Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance
   Hyein Jo et al, 2023, International Journal of Molecular Sciences CrossRef
9. The Emerging Role of m6A Modification in Endocrine Cancer
   Xiaoyu Ji et al, 2023, Cancers CrossRef
10. Regulatory role of RNA modifications in the treatment of pancreatic ductal adenocarcinoma (PDAC)
    Hao Chen et al, 2023, Heliyon CrossRef
11. New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC
    Wenli Cheng et al, 2022, Frontiers in Pharmacology CrossRef
12. Role of N6‑methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review)
    Tong Ye et al, 2022, International Journal of Oncology CrossRef
13. The m6A methylation landscape, molecular characterization and clinical relevance in prostate adenocarcinoma
    Chao Li et al, 2023, Frontiers in Immunology CrossRef
14. METTLing in Stem Cell and Cancer Biology
    John G. Tooley et al, 2023, Stem Cell Reviews and Reports CrossRef
15. The novel m6A writer METTL5 as prognostic biomarker probably associating with the regulation of immune microenvironment in kidney cancer
    null Wei Zhang et al, 2022, Heliyon CrossRef
16. METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation
    Chengjie Lin et al, 2023, Cell Death & Disease CrossRef
17. METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression
    Peng Xia et al, 2023, Cancer Communications CrossRef